Subscribe
Aguadeluna / Shutterstock.com
11 March 2025NewsBig PharmaSarah Speight

Novo Nordisk strikes again over Wegovy generic

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun Pharma.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
11 September 2024   Danish multinational asks Delaware court to block semaglutide generics from Sun Pharma and Mylan | ANDAs infringe two claims of patent granted in July, Novo claims.


Editor's picks

Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025

Editor's picks

Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025
Americas
Fed Circ ruling on Wuhan import ban shakes up economic prong analysis
11 February 2025
Americas
Regeneron holds off copies of $6bn eye treatment
4 February 2025
Careers
Bristows appoints Irish patent attorney to boost UPC representation
4 February 2025
Americas
New national rankings recognise top US patent firms and lawyers
4 February 2025

More on this story

Americas
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
11 September 2024   Danish multinational asks Delaware court to block semaglutide generics from Sun Pharma and Mylan | ANDAs infringe two claims of patent granted in July, Novo claims.

More on this story

Americas
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
11 September 2024   Danish multinational asks Delaware court to block semaglutide generics from Sun Pharma and Mylan | ANDAs infringe two claims of patent granted in July, Novo claims.

More features

Fed Circ removes Apple import watch ban threat
Blank Rome bolsters patent litigation with Houston partner hire
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
Regeneron edges closer to Eylea market exclusivity amid biosimilar threats
Teva can’t revive Orange book inhaler battle at Fed Circ
Jones Day adds experienced patent litigators from Weil
WIPR Leaders revamps selection process for 2025 edition